Status:
COMPLETED
Clinical Correlation Study Between Anomalous Pancreaticobiliary Ductal Junction and Malignant Tumors of the Biliary System and the Establishment of an AI-based Automated Recognition System
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Pancreaticobiliary Maljunction
Eligibility:
All Genders
Brief Summary
To explore the occurrence of pancreaticobiliary maljunction (PBM) in the Chinese population, the characteristics of various subtypes, and the relationship between PBM and malignant tumors of the bilia...
Eligibility Criteria
Inclusion
- Cases that were hospitalized and underwent Magnetic resonance cholangiopancreatography (MRCP) examination at the First Medical Center of Chinese People's Liberation Army General Hospital.
Exclusion
- Patients aged less than 18 years old;
- Those with unclear diagnosis;
- Cases with missing or poor-quality imaging data.
Key Trial Info
Start Date :
April 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2024
Estimated Enrollment :
2439 Patients enrolled
Trial Details
Trial ID
NCT06903520
Start Date
April 1 2023
End Date
April 1 2024
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese People's Liberation Army General Hospital
Beijing, China, 100000